New York, The global direct-to-consumer (DTC) genetic testing market was valued at USD 1.4 Billion in 2021 and it is anticipated to grow up to USD 5.0 Billion by 2031, at a CAGR of 13.7% during the forecast period.
Direct-to-consumer (DTC) genetic testing is a type of genetic testing that is done without the involvement of a healthcare provider. DTC tests are often done through mail-order kits, and the results are usually provided directly to the consumer without the need for interpretation by a healthcare provider.
Request free sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS24318/
Market Trends and Drivers
Rising demand for personalized direct-to-consumer genetic testing services will boost the market expansion
Increasing demand for personalized direct-to-consumer genetic tests will promote the market growth as customers are willing to pay for the identification and addressing of specific needs. Surging popularity of pharmacogenetics will also positively promote the direct-to-consumer genetic testing industry statistics. As pharmacogenetics is the well-known example of gene-based personalization, where genetic polymorphisms dictate the selection of medicinal treatment that favors the business momentum. Moreover, the evaluation and regulation of personalized tests are based on consumer’s understanding. The service provider offers descriptive information regarding analytical validity, and clinical validity of the tests that surges its industry demand. These personalised tests are also less expensive than regular genetic screenings. Furthermore, personalised direct-to-consumer genetic test results can be generated fast using easy and noninvasive technologies. These aforementioned factors will accelerate the overall market share.
Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS24318/
Market Segments
The direct-to-consumer genetic testing market is segmented by product, technology, sample, and region. By product, the market is classified into pharmacogenetics tests, carrier screening tests, and others. Based on technology, it is bifurcated into single nucleotide polymorphism chip, and whole genome sequencing. On the basis of the sample, it is divided into saliva, urine, and blood. Region-wise, the market is segmented into North America, Europe, Asia Pacific, and the rest of the World.
Key Players
The direct-to-customer genetic testing market includes players such as 23andMe, Ancestry DNA, Color Genomics Inc., Family Tree DNA, Full Genomes Corporation Inc., Helix OpCo LLC, Identigene LLC, Living DNA Ltd., MyHeritage Ltd., Prenetics Limited, and others.
Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS24318/
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700